Business Wire

NY-MHW-LTD

16.11.2021 16:02:11 CET | Business Wire | Press release

Share
MHW Expands Global Wine Importation and Distribution Footprint Through Acquisition of USA Wine West and USA Wine Imports

MHW, Ltd., the leading service provider for wine, spirits, beer and cider in the United States, has announce the successful acquisition of two nationally licensed importation companies, USA Wine West and USA Wine Imports, each of whom have decades of experience in fine wine distribution, logistics management, market strategy, compliance and administration.

“Over the last 25 years, USA Wine West has provided unparalleled logistics, compliance and administrative import services to foreign and domestic wineries who launch in the U.S.,” says Founder Steve Melchiskey, who will continue leading the USA Wine West team and join MHW as Vice President of Sales and Development. “Becoming a part of MHW enables us to carry on that mission with greater resources and capabilities. This is especially exciting for the passionate wineries and individuals we work with, as well as our world-class team who has been critical to this success.”

MHW, USA Wine West and USA Wine Imports will continue to service their respective client portfolios while they explore additional ways to deliver value through their partnership with clients over time by expanding on service capabilities, such as global consolidated logistics and more comprehensive direct-to-retail offerings.

“MHW is thrilled to welcome USA Wine West and USA Wine Imports to our team,” says MHW Chief Executive Officer Gabe Barkley. “Both companies enhance our leadership in serving the needs of the global fine wine market across all segments. We share a common DNA of building and valuing lasting client relationships. That orientation toward partnership is vital to our ongoing success. Because my career began in fine wine retail, I am personally thrilled about our expanded ability to help wine producers – from family-owned wineries to private-label programs – establish their presence in the U.S. market alongside our existing leadership positions in spirits and malt beverages.”

“It has been gratifying and humbling to have presided over a period of incredible growth at USA Wine Imports and we are very excited to be passing the baton to such a capable partner in MHW,” says former USA Wine Imports Vice President Nicolas Mestre. “This partnership will allow our portfolios the additional resources they require to scale and thrive in the market.” Sandi Bartel, USA Wine’s longtime General Manager, will continue to manage day-to-day operations.

About MHW, LTD.

MHW, LTD . is the leading beverage alcohol service partner in the United States, European Union and United Kingdom, specializing in strategic, scalable back-office solutions including compliance management, licensing, operations, logistics, fulfillment, accounting, business insight reporting, and technology. Since 1995, MHW has served as the national importer and distributor to international brands of all sizes, helping more than 100,000 wine, spirits and beer products successfully enter the U.S. MHW’s global wholesale capabilities give clients access to the retail trade in four key U.S. markets, the EU and UK. Companies who partner with MHW have the competitive advantage to focus time and effort on building brand sales. With strategic and attentive teams who have decades of back-office beverage alcohol experience, MHW offers unparalleled expertise and service excellence. To learn how to make your mark in the US and EU, please visit mhwltd.com .

About USA Wine West

USA Wine West is a premier provider of national wine import services in the U.S. A fully licensed federal importer, they work in partnership with the sales and marketing teams of foreign and domestic wineries to distribute wine to wholesalers in all 50 states. They work strategically with client portfolios to provide a cost-effective, integrated sales platform, along with an efficient logistical and compliance system designed to support foreign wineries to succeed in this competitive market.

About USA Wine Imports

USA Wine Imports is a national importer of wine and spirits providing wholesale customers distribution in all major wine markets in the U.S. USA Wine Imports works closely with wine and spirits producers, importers, brokers and agents to develop innovative sales and marketing strategies and meet ambitious sales goals in a crowded marketplace. In addition, they handle import, freight, compliance, licensing, warehousing, order fulfillment, invoicing, inventory control and accounting services.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye